Already in the 90s, Khachaturian stated that postponing dementia onset by five years would decrease the prevalence of the late onset dementia by 50%. After two decades of lack of success in dementia drug discovery and development, and knowing that worldwide, currently 36 million patients have been diagnosed with Alzheimer's disease, a number that will double by 2030 and triple by 2050, the World Health Organization and the Alzheimer's Disease International declared that prevention of cognitive decline was a 'public health priority. ' Numerous longitudinal studies and meta-analyses were conducted to analyze the risk and protective factors for dementia. Among the 93 identified risk factors, seven major modifiable ones should be considered: low education, sedentary lifestyle, midlife obesity, midlife smoking, hypertension, diabetes, and midlife depression. Three other important modifiable risk factors should also be added to this list: midlife hypercholesterolemia, late life atrial fibrillation, and chronic kidney disease. After their identification, numerous authors attempted to establish dementia risk scores; however, the proposed values were not convincing. Identifying the possible interventions, able to either postpone or delay dementia has been an important challenge. Observational studies focused on a single life-style intervention increased the global optimism concerning these possibilities. However, a recent extensive literature review of the randomized control trials (RCTs) conducted before 2014 yielded negative results. The first results of RCTs of multimodal interventions (Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability, Multidomain Alzheimer Prevention Study, and Prediva) brought more optimism. Lastly, interventions targeting compounds of beta amyloid started in 2012 and no results have yet been published.
INTRODUCTION
As early as the 90s, Khachaturian stated that delaying the onset of dementia by five years would decrease the prevalence of late-onset dementia by 50%. 1) After two decades without any major advances in the discovery or development of dementia drugs, 2) in a landmark report, the World Health Organization and Alzheimer's Disease International stated that prevention of cognitive decline had become a 'public health priority, ' given that, at the time of the publication, 36 million patients worldwide were diagnosed with Alzheimer's disease (AD), and this number was set to double by 2030 and triple by 2050. 3) However, surprisingly, the 1975-2015 report of the Framingham Heart study showed a 20% decrease in dementia incidence for each decade, while the prevalence of overweight and cardiovascular events did not decrease at the same rate, over the same period of time. 4) The debate is on-going, since no such decline was observed either in the Rotterdam study or in the low-and middle-resource countries, whose ageing population will grow faster than that of the developed, high-resource countries. Application of this score to the Kaiser Permanente cohort, which included 9,480 participants with a baseline age between 40 and 55 years,
showed that after 40 years of follow-up, the score allowed stratification of participants into those with 40-year low (9%) and high (29%) dementia risk. 13 
OBSERVATIONAL STUDIES FOCUSED ON A SINGLE SPECIFIC LIFESTYLE INTERVENTION
The first observational study showing the possible impact of fish intake on dementia prevention was published in 1997. The 2.1-year followup of 5,386 participants without dementia, aged over 55 years at baseline, showed that eating fish, an important source of n-3 polyunsaturated fatty acids, was inversely related to the incidence of dementia (RR, 0.4; 95% CI, 0.2 to 0.91). 17) More recently, a significant positive relationship was observed between fish consumption and functional cortical activity in a population of 142 Japanese workers, suggesting that fish consumption modulates functional activity in the left dorsolateral prefrontal cortex. 18) Regarding physical activity, a meta-analysis of 15 prospective studies (mean length of follow-up 5 years) that altogether included 33,816 adults, aged over 65 years (12 cohorts from Canada, China, Europe, Singapore, and the USA), who did not show cognitive impairment at study inclusion, showed that moderate to high physical activity protects significantly against cognitive decline (P<0.00001).
19)

RANDOMIZED CONTROL TRIALS OF ONE SPECIFIC NTERVENTION
The aforementioned survey of randomized control trials (RCTs) pub- 
ONGOING INTERVENTIONS TARGETING COMPOUNDS OF BETA AMYLOID
Up to now, only study protocols have been published for studies in this domain, of which several have just started (between 2012 and 2014).
The studies target autosomal dominant early-onset Alzheimer's disease (two) and asymptomatic Alzheimer's disease (one). 21) Results will be eagerly awaited. 
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